E7019
Exendin-3
≥97%
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C184H282N50O61S
CAS Number:
Molecular Weight:
4202.57
UNSPSC Code:
51111800
MDL number:
General description
Exendin-3 is a pancreatic secretagogue, which is a member of the glucagon family. It is found in the venom of Heloderma horridurn, which is a Gila monster lizard. It has a molecular mass of 4200Da and is composed of 39 amino acids. 12 amino-acids region in its N-terminal is highly homologous to secretin. Its C-terminal contains an amide group.
Application
Exendin-3 has been used to assess its effect in glucagon receptor knockout mice (Gcgr-/-) and wild-type mice, on glucose-stimulated insulin secretion.
Other Notes
Originally isolated from Heloderma horridum (Gila monster lizard) venom.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Actions of Helodermatidae venom peptides and mammalian glucagon-like peptides on gastric chief cells.
Rai, A., et al.
The American Journal of Physiology, 265 (1993)
Bioactive peptides from lizard venoms.
J P Raufman
Regulatory peptides, 61(1), 1-18 (1996-01-16)
J Eng et al.
The Journal of biological chemistry, 265(33), 20259-20262 (1990-11-25)
An amino-terminal histidyl structure (His1) is characteristic of most peptides in the glucagon superfamily. An assay for His1 peptides performed by amino-terminal amino acid sequencing was used to screen venom from the Gila monster lizard, Heloderma horridum. Two His1 peptides
Heidi Sørensen et al.
Diabetes, 55(12), 3463-3469 (2006-11-30)
In previous studies, glucagon receptor knockout mice (Gcgr(-/-)) display reduced blood glucose and increased glucose tolerance, with hyperglucagonemia and increased levels of glucagon-like peptide (GLP)-1. However, the role of glucagon receptor signaling for the regulation of islet function and insulin
S A Beak et al.
The Journal of clinical investigation, 101(6), 1334-1341 (1998-04-29)
To examine the influence of the putative satiety factor (GLP-1) on the hypothalamo-pituitary-gonadal axis, we used GT1-7 cells as a model of neuronal luteinizing hormone- releasing hormone (LHRH) release. GLP-1 caused a concentration-dependent increase in LHRH release from GT1-7 cells.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service